RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 820 filers reported holding RAYTHEON CO in Q1 2015. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $236,000 | +12.4% | 1,072 | 0.0% | 0.04% | +5.1% |
Q3 2019 | $210,000 | +4.5% | 1,072 | -7.1% | 0.04% | +2.6% |
Q2 2019 | $201,000 | -2.0% | 1,154 | +2.5% | 0.04% | -5.0% |
Q1 2019 | $205,000 | -3.3% | 1,126 | +9.9% | 0.04% | -2.4% |
Q3 2018 | $212,000 | -5.8% | 1,025 | -12.0% | 0.04% | -10.9% |
Q2 2018 | $225,000 | -25.7% | 1,165 | -17.0% | 0.05% | -27.0% |
Q1 2018 | $303,000 | +0.3% | 1,403 | -12.6% | 0.06% | 0.0% |
Q4 2017 | $302,000 | +0.7% | 1,606 | 0.0% | 0.06% | -4.5% |
Q3 2017 | $300,000 | +4.2% | 1,606 | -9.8% | 0.07% | 0.0% |
Q2 2017 | $288,000 | +3.6% | 1,781 | -2.5% | 0.07% | +1.5% |
Q1 2017 | $278,000 | -4.1% | 1,826 | -10.5% | 0.06% | -9.7% |
Q4 2016 | $290,000 | +4.3% | 2,041 | 0.0% | 0.07% | +1.4% |
Q3 2016 | $278,000 | +0.4% | 2,041 | 0.0% | 0.07% | -4.1% |
Q2 2016 | $277,000 | -3.1% | 2,041 | -12.4% | 0.07% | -5.1% |
Q1 2016 | $286,000 | -25.3% | 2,331 | -24.2% | 0.08% | -27.1% |
Q4 2015 | $383,000 | +1.9% | 3,076 | -10.6% | 0.11% | -3.6% |
Q3 2015 | $376,000 | -13.8% | 3,440 | -24.0% | 0.11% | -9.0% |
Q2 2015 | $436,000 | -32.3% | 4,524 | -23.2% | 0.12% | -34.1% |
Q1 2015 | $644,000 | -33.7% | 5,894 | -34.4% | 0.18% | -36.0% |
Q4 2014 | $972,000 | -37.8% | 8,983 | -41.5% | 0.29% | -40.5% |
Q3 2014 | $1,562,000 | +8.1% | 15,368 | -1.9% | 0.49% | +6.6% |
Q2 2014 | $1,445,000 | +1.5% | 15,663 | +8.7% | 0.46% | -4.4% |
Q1 2014 | $1,423,000 | +14.3% | 14,404 | +4.9% | 0.48% | +9.2% |
Q4 2013 | $1,245,000 | +15.3% | 13,725 | +0.0% | 0.44% | -0.5% |
Q3 2013 | $1,080,000 | +18.4% | 13,720 | -0.5% | 0.44% | +17.7% |
Q2 2013 | $912,000 | – | 13,791 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |